These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2311334)

  • 1. Clinical and pharmacokinetic properties of a transdermal nicotine patch.
    Mulligan SC; Masterson JG; Devane JG; Kelly JG
    Clin Pharmacol Ther; 1990 Mar; 47(3):331-7. PubMed ID: 2311334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal nicotine facilitates smoking cessation.
    Rose JE; Levin ED; Behm FM; Adivi C; Schur C
    Clin Pharmacol Ther; 1990 Mar; 47(3):323-30. PubMed ID: 2178852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments.
    Fiore MC; Kenford SL; Jorenby DE; Wetter DW; Smith SS; Baker TB
    Chest; 1994 Feb; 105(2):524-33. PubMed ID: 8306757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving.
    Selby P; Andriash K; Zawertailo L; Persad D; Zack M; Busto UE
    J Clin Psychopharmacol; 2013 Oct; 33(5):667-74. PubMed ID: 23963055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transdermal nicotine patch: results of a randomised placebo-controlled trial.
    Richmond RL; Harris K; de Almeida Neto A
    Med J Aust; 1994 Jul; 161(2):130-5. PubMed ID: 8028537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation.
    Perng RP; Hsieh WC; Chen YM; Lu CC; Chiang SJ
    J Formos Med Assoc; 1998 Aug; 97(8):547-51. PubMed ID: 9747065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting smoking cessation. Who will quit with and without the nicotine patch.
    Kenford SL; Fiore MC; Jorenby DE; Smith SS; Wetter D; Baker TB
    JAMA; 1994 Feb; 271(8):589-94. PubMed ID: 8301790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetic model of transdermal nicotine delivered from a matrix-type patch.
    Linakis MW; Rower JE; Roberts JK; Miller EI; Wilkins DG; Sherwin CMT
    Br J Clin Pharmacol; 2017 Dec; 83(12):2709-2717. PubMed ID: 28771779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatment.
    Gourlay SG; Benowitz NL; Forbes A; McNeil JJ
    Eur J Clin Pharmacol; 1997; 51(5):407-14. PubMed ID: 9049583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study.
    Daughton DM; Heatley SA; Prendergast JJ; Causey D; Knowles M; Rolf CN; Cheney RA; Hatlelid K; Thompson AB; Rennard SI
    Arch Intern Med; 1991 Apr; 151(4):749-52. PubMed ID: 2012458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.
    Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG
    JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation.
    Tønnesen P; Nørregaard J; Simonsen K; Säwe U
    N Engl J Med; 1991 Aug; 325(5):311-5. PubMed ID: 2057036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal nicotine and smoking behavior in psychiatric patients.
    Hartman N; Leong GB; Glynn SM; Wilkins JN; Jarvik ME
    Am J Psychiatry; 1991 Mar; 148(3):374-5. PubMed ID: 1992843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo.
    Jamerson BD; Nides M; Jorenby DE; Donahue R; Garrett P; Johnston JA; Fiore MC; Rennard SI; Leischow SJ
    Clin Ther; 2001 May; 23(5):744-52. PubMed ID: 11394732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose nicotine patch therapy. Percentage of replacement and smoking cessation.
    Dale LC; Hurt RD; Offord KP; Lawson GM; Croghan IT; Schroeder DR
    JAMA; 1995 Nov; 274(17):1353-8. PubMed ID: 7563559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose transdermal nicotine therapy for heavy smokers: safety, tolerability and measurement of nicotine and cotinine levels.
    Fredrickson PA; Hurt RD; Lee GM; Wingender L; Croghan IT; Lauger G; Gomez-Dahl L; Offord KP
    Psychopharmacology (Berl); 1995 Dec; 122(3):215-22. PubMed ID: 8748390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol changes in smoking cessation using the transdermal nicotine system. Transdermal Nicotine Study Group.
    Allen SS; Hatsukami D; Gorsline J
    Prev Med; 1994 Mar; 23(2):190-6. PubMed ID: 8047525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine replacement therapy for smoking cessation.
    Silagy C; Mant D; Fowler G; Lancaster T
    Cochrane Database Syst Rev; 2000; (3):CD000146. PubMed ID: 10908462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobacco dependence and the nicotine patch. Clinical guidelines for effective use.
    Fiore MC; Jorenby DE; Baker TB; Kenford SL
    JAMA; 1992 Nov; 268(19):2687-94. PubMed ID: 1304736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term quit rates after a perioperative smoking cessation randomized controlled trial.
    Lee SM; Landry J; Jones PM; Buhrmann O; Morley-Forster P
    Anesth Analg; 2015 Mar; 120(3):582-587. PubMed ID: 25695576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.